Pivot Pharmaceuticals Inc

Pivot Pharmaceuticals Inc

  • Price (EUR)0.2133
  • Today's Change-0.001 / -0.56%
  • Shares traded0.00
  • 1 Year change-19.20%
  • Beta--
Data delayed at least 15 minutes, as of Sep 18 2019 08:05 BST.
More ▼

Financials data is unavailable for this security.

Cash flow in CADView more

In 2019, cash reserves at Pivot Pharmaceuticals Inc fell by 4.50k. Cash Flow from Financing totalled 5.83m or -- of revenues. In addition the company used 4.98m for operations while cash used for investing totalled 850.51k.
Cash flow per share--
Price/Cash flow per share--
Book value per share0.0318
Tangible book value per share-0.0462
More ▼

Balance sheet in CADView more

Pivot Pharmaceuticals Inc has a Debt to Total Capital ratio of 46.52%.
Current ratio0.0365
Quick ratio--
Total debt/total equity0.8698
Total debt/total capital0.4652
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.